Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05058508 · ClinicalTrials.gov registry record · NA
LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
A NA study of Pediatric Cancer, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05058508: Recruiting NA study of Pediatric Cancer, sponsored by Wake Forest University Health Sciences.
NCT05058508 is a NA study of Pediatric Cancer that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 60 participants, below the 1,489-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05058508, a NA study of Pediatric Cancer, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
Primary Outcome
Investigate if 30 minutes of exercise, five days per week, will have benefit relative to the control arm by increasing and/or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by 6-Minute Walk test
Conditions Studied
Interventions
- OTHER "Just Move" Exercise
- OTHER Standard of Care Exercise
Study Locations (1)
North Carolina
- Levine Children's Hospital - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-03-11 |
| Est. Completion | 2027-11 |
| Phase | NA |
What NCT05058508 shows while recruiting
NCT05058508 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,489-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 2 interventions - of which "Just Move" Exercise is the first listed.
NCT05058508 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05058508 about?
NCT05058508 is a clinical study titled "LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients". The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
What is the current status of trial NCT05058508?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-03-11. Estimated completion is 2027-11.
What conditions does trial NCT05058508 study?
This clinical trial studies the following conditions: Pediatric Cancer.
What interventions are being tested in trial NCT05058508?
The interventions under investigation include: "Just Move" Exercise (OTHER), Standard of Care Exercise (OTHER).
Who is sponsoring clinical trial NCT05058508?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05058508 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05058508's enrollment target sits among peer trials
60 26th of 51 higher than 24 of 51 other Pediatric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Digital Art Therapy for Young Cancer Survivors
RECRUITING · NA
-
Medically Tailored Meals for Kids
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI